期刊文献+

Khorana评估表在预防恶性淋巴瘤患者深静脉血栓中的应用研究 被引量:4

下载PDF
导出
摘要 目的探讨Khorana评估表在预防恶性淋巴瘤患者深静脉血栓中的应用效果。方法选取2018年11月-2019年5月本科住院的恶性淋巴瘤400例,按入院先后顺序分为干预组和对照组,每组各200例,对照组采用传统的护理方法,干预组应用Khorana评估表对患者进行深静脉血栓危险因素评估,根据评估结果实施针对性预防护理措施。结果干预组患者深静脉血栓发生率低于对照组,差异具有统计学意义(P<0.05)。结论应用Khorana评估表能有效预测发生深静脉血栓的高危人群,从而实施有效的护理干预,降低深静脉血栓的发生率。
出处 《护士进修杂志》 2020年第12期1133-1136,共4页 Journal of Nurses Training
关键词 恶性淋巴瘤 Khorana评估表 深静脉血栓 护理 Malignant lymphoma Khorana evaluation form Deep vein thrombosis Nursing
  • 相关文献

参考文献5

二级参考文献36

  • 1胡豫,王华芳.肿瘤并发血栓形成机制及治疗[J].中国实用内科杂志,2007,27(20):1591-1593. 被引量:11
  • 2Goldschmidt N, Linetsky E, Shalom E, et al. High incidence of thromboembolism in patients with central nervous system lymphomam. Cancer, 2003, 98(6):1239-1242.
  • 3Yokoyama K, Murata M, Ikeda Y, et al. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large B-ceillymphomam. Thromb Res, 2012, 130(1):7-11.
  • 4Caruso V, Di Castelnuovo A, Meschengieser S, et al. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events m. Blood, 2010, 115(26):5322-5328.
  • 5Park LC, Woo SY, Kim S, et al. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population m. Thromb Res, 2012, 130(3):e6-e12.
  • 6Reitsma PH, Versteeg HH, Middeldorp S. Mechanistic view of risk factors for venous thromboembolism[J]. Arterioscler Thromb Vase Bioi, 2012, 32(3):563-568.
  • 7Rak J, Milsom C, May L, et al. Tissue factor in cancer and angio- genesis: the molecular link between genetic tumor progression. tumor neovascularization, and cancer coagulopathy[J]. Semin Thromb He most, 2006, 32(1):54-70.
  • 8Sartori MT, Della Puppa A, Ballin A, et al. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticiesm.J Neurooncol, 2011, 104(1) :22.5-231.
  • 9Roselli M, Ferroni P, Rolfo C, et al. TNF-n gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy[J], Ann Oncol, 2013, 24 (10) :2571-2575.
  • 10Gonsalves A, Carrier M, Wells PS, et al. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantationm.J Thromb Haemost, 2008, 6(9) :1468-1473.

共引文献37

同被引文献48

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部